Detail
| RLID: | RLID00030177 |
| RNA Symbol: | hsa-miR-1-3p |
| RNA Category: | miRNA |
| Organism: | Homo sapiens |
| Aliase: | hsa-miR-1 |
| Subcellular Localization: | |
| Localization | Tissue | Validated Method | PMID |
| Circulating | Serum | Next-generation sequencing | 20194856 |
| Description: Endogenous circulating miRNAs are stable, are well protected from RNases, and remain stable even after being subjected to harsh conditions. Eleven serum miRNAs were found to be altered more than five-fold by Solexa sequencing between longer-survival and shorter-survival groups, and levels of four miRNAs (ie, miR-486, miR-30d, miR-1 and miR-501) were significantly associated with overall survival. | |||
Other Subcellular Localization:
| RLID | Localization | Tissue | Validated Method | PMID |
| RLID00030178 | Circulating | Serum | Next-generation sequencing | 23641832 |
| RLID00030179 | Circulating | Serum | - | 24456939 |
| RLID00030180 | Cytoplasm | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00030181 | Exosome | Brain tissue | Microarray | 23382797 |
| RLID00030182 | Exosome | Plasma | Next-generation sequencing | 23663360 |
| RLID00030183 | Microvesicle | Plasma | Next-generation sequencing | 23077538 |
| RLID00030184 | Mitochondrion | Skeletal muscular cell | In situ hybridization|qRT-PCR | 21637849 |
| RLID00030185 | Mitochondrion | HeLa cell | Next-generation sequencing | 22984580 |
| RLID00030186 | Mitochondrion | Eembryonic kidney cell | Next-generation sequencing | 22984580 |
| RLID00030187 | Nucleus | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00030188 | Exosome | Serum | Next-generation sequencing | 24683445 |
| RLID00030189 | Exosome | Myocard | - | 22529849 |
| RLID00030190 | Circulating | Serum | Next-generation sequencing | 22719975 |